Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01822158 · ClinicalTrials.gov registry record · NA
Vaginal Delivery Debrief Checklist to Improve Team Communication
A NA study, sponsored by Providence Health & Services.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT01822158: Completed NA study, sponsored by Providence Health & Services.
NCT01822158 is a NA study that has completed, run by Providence Health & Services. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01822158, a NA study, has completed, sponsored by Providence Health & Services.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
This study is to determine if using a standardized debrief checklist after vaginal delivery improves communication between the vaginal delivery health care team members and if using the checklist increases a sense of enhanced communication between team members.
Primary Outcome
An electronic opinion survey will be administered to participants both pre and post checklist utilization. The survey was derived from communication literature on medical teams such as the collaboration items and 3 subscales from the labour and delivery version of the Safety Attitudes Questionnaire (SAQ) and the Agency for Healthcare Research and Quality (AHRQ) TeamSTEPPS training program for high functioning medical teams.
Interventions
- OTHER Vaginal Delivery Debrief Checklist
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2013-05-12 |
| Est. Completion | 2013-12-31 |
| Phase | NA |
What the finished NCT01822158 record still lists
NCT01822158 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which Vaginal Delivery Debrief Checklist is the first listed.
NCT01822158 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01822158 about?
NCT01822158 is a clinical study titled "Vaginal Delivery Debrief Checklist to Improve Team Communication". This study is to determine if using a standardized debrief checklist after vaginal delivery improves communication between the vaginal delivery health care team members and if using the checklist increases a sense of enhanced communication between team members.
What is the current status of trial NCT01822158?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2013-05-12. Estimated completion is 2013-12-31.
What interventions are being tested in trial NCT01822158?
The interventions under investigation include: Vaginal Delivery Debrief Checklist (OTHER).
Who is sponsoring clinical trial NCT01822158?
This trial is sponsored by Providence Health & Services, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01822158's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI